CASI logo

CASI Pharmaceuticals (CASI) Cash From Operations

Annual CFO

-$19.97 M
+$1.12 M+5.32%

December 31, 2023


Summary


Performance

CASI Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCASIcash flowmetrics:

Quarterly CFO

N/A

September 1, 2024


Summary


Performance

CASI Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCASIcash flowmetrics:

TTM CFO

N/A

September 1, 2024


Summary


Performance

CASI TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCASIcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CASI Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.3%--
3 y3 years+22.9%--
5 y5 years+30.1%--

CASI Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+25.6%
5 y5-yearat high+25.6%
alltimeall time-807.6%+62.2%

CASI Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2023
-$19.97 M(-5.3%)
-
-
Dec 2022
-$21.09 M(-21.4%)
-$843.00 K(-87.1%)
-$21.09 M(-24.4%)
Sep 2022
-
-$6.52 M(-31.2%)
-$27.89 M(+10.6%)
Jun 2022
-
-$9.48 M(+123.8%)
-$25.22 M(+9.3%)
Mar 2022
-
-$4.24 M(-44.5%)
-$23.08 M(-14.0%)
Dec 2021
-$26.84 M(+3.7%)
-$7.64 M(+98.0%)
-$26.84 M(-1.4%)
Sep 2021
-
-$3.86 M(-47.4%)
-$27.23 M(-9.8%)
Jun 2021
-
-$7.34 M(-8.3%)
-$30.20 M(+3.2%)
Mar 2021
-
-$8.00 M(-0.4%)
-$29.25 M(+13.0%)
Dec 2020
-$25.89 M(+11.4%)
-$8.03 M(+17.6%)
-$25.89 M(+14.2%)
Sep 2020
-
-$6.83 M(+6.9%)
-$22.67 M(+10.1%)
Jun 2020
-
-$6.39 M(+37.9%)
-$20.59 M(-9.1%)
Mar 2020
-
-$4.63 M(-3.8%)
-$22.66 M(-2.5%)
Dec 2019
-$23.24 M(-18.7%)
-$4.82 M(+1.5%)
-$23.24 M(-30.8%)
Sep 2019
-
-$4.75 M(-43.9%)
-$33.57 M(+2.0%)
Jun 2019
-
-$8.46 M(+62.2%)
-$32.92 M(+18.3%)
Mar 2019
-
-$5.22 M(-65.6%)
-$27.83 M(-2.6%)
Dec 2018
-$28.58 M(+346.5%)
-$15.15 M(+270.1%)
-$28.58 M(+93.2%)
Sep 2018
-
-$4.09 M(+21.1%)
-$14.79 M(+20.5%)
Jun 2018
-
-$3.38 M(-43.4%)
-$12.27 M(+13.2%)
Mar 2018
-
-$5.97 M(+340.3%)
-$10.84 M(+69.3%)
Dec 2017
-$6.40 M(+6.3%)
-$1.36 M(-13.8%)
-$6.40 M(-3.3%)
Sep 2017
-
-$1.57 M(-19.2%)
-$6.62 M(-1.1%)
Jun 2017
-
-$1.95 M(+27.1%)
-$6.69 M(+9.5%)
Mar 2017
-
-$1.53 M(-2.8%)
-$6.11 M(+1.5%)
Dec 2016
-$6.02 M(+9.2%)
-$1.57 M(-4.3%)
-$6.02 M(+4.9%)
Sep 2016
-
-$1.65 M(+20.7%)
-$5.74 M(+2.2%)
Jun 2016
-
-$1.36 M(-5.4%)
-$5.62 M(-2.2%)
Mar 2016
-
-$1.44 M(+11.6%)
-$5.74 M(+4.2%)
Dec 2015
-$5.51 M(+38.0%)
-$1.29 M(-15.2%)
-$5.51 M(+3.6%)
Sep 2015
-
-$1.52 M(+2.2%)
-$5.32 M(+10.3%)
Jun 2015
-
-$1.49 M(+23.1%)
-$4.82 M(+11.8%)
Mar 2015
-
-$1.21 M(+9.9%)
-$4.32 M(+8.0%)
Dec 2014
-$4.00 M(+22.0%)
-$1.10 M(+7.5%)
-$4.00 M(+10.7%)
Sep 2014
-
-$1.02 M(+4.5%)
-$3.61 M(-8.9%)
Jun 2014
-
-$980.40 K(+10.1%)
-$3.96 M(-1.6%)
Mar 2014
-
-$890.10 K(+24.7%)
-$4.03 M(+22.9%)
Dec 2013
-$3.28 M(+48.1%)
-$714.00 K(-48.1%)
-$3.28 M(-0.4%)
Sep 2013
-
-$1.38 M(+31.5%)
-$3.29 M(+5.0%)
Jun 2013
-
-$1.05 M(+647.9%)
-$3.13 M(-5.1%)
Mar 2013
-
-$139.90 K(-80.7%)
-$3.30 M(+49.1%)
Dec 2012
-$2.21 M(-48.2%)
-$726.30 K(-40.4%)
-$2.21 M(-7.5%)
Sep 2012
-
-$1.22 M(+0.3%)
-$2.39 M(-19.2%)
Jun 2012
-
-$1.21 M(-228.3%)
-$2.96 M(-21.8%)
Mar 2012
-
$946.80 K(-204.6%)
-$3.79 M(-11.3%)
Dec 2011
-$4.27 M(-13.9%)
-$905.50 K(-49.4%)
-$4.27 M(-7.8%)
Sep 2011
-
-$1.79 M(-12.4%)
-$4.63 M(-7.4%)
Jun 2011
-
-$2.04 M(-541.1%)
-$5.00 M(-4.3%)
Mar 2011
-
$462.70 K(-136.5%)
-$5.23 M(+5.5%)
Dec 2010
-$4.96 M(-51.4%)
-$1.27 M(-41.3%)
-$4.96 M(-7.3%)
Sep 2010
-
-$2.16 M(-4.8%)
-$5.35 M(-15.7%)
Jun 2010
-
-$2.27 M(-409.2%)
-$6.34 M(-19.3%)
Mar 2010
-
$733.40 K(-144.3%)
-$7.86 M(-23.0%)
Dec 2009
-$10.21 M
-$1.66 M(-47.5%)
-$10.21 M(-1.6%)
DateAnnualQuarterlyTTM
Sep 2009
-
-$3.15 M(-16.8%)
-$10.38 M(-27.6%)
Jun 2009
-
-$3.79 M(+134.6%)
-$14.34 M(-20.7%)
Mar 2009
-
-$1.62 M(-11.5%)
-$18.08 M(-12.7%)
Dec 2008
-$20.71 M(-11.9%)
-$1.83 M(-74.3%)
-$20.71 M(-8.1%)
Sep 2008
-
-$7.11 M(-5.5%)
-$22.54 M(+0.5%)
Jun 2008
-
-$7.52 M(+76.9%)
-$22.43 M(-3.5%)
Mar 2008
-
-$4.25 M(+16.5%)
-$23.24 M(-1.2%)
Dec 2007
-$23.52 M(+13.2%)
-$3.65 M(-47.9%)
-$23.52 M(-4.9%)
Sep 2007
-
-$7.00 M(-15.9%)
-$24.73 M(+5.6%)
Jun 2007
-
-$8.33 M(+83.7%)
-$23.43 M(+18.0%)
Mar 2007
-
-$4.54 M(-6.6%)
-$19.85 M(-4.4%)
Dec 2006
-$20.77 M(+43.1%)
-$4.86 M(-14.7%)
-$20.77 M(+6.1%)
Sep 2006
-
-$5.70 M(+19.8%)
-$19.57 M(+8.2%)
Jun 2006
-
-$4.76 M(-12.8%)
-$18.09 M(-5.1%)
Mar 2006
-
-$5.46 M(+49.1%)
-$19.05 M(+31.2%)
Dec 2005
-$14.52 M(-11.5%)
-$3.66 M(-13.2%)
-$14.52 M(+9.3%)
Sep 2005
-
-$4.21 M(-26.4%)
-$13.28 M(+5.0%)
Jun 2005
-
-$5.72 M(+519.7%)
-$12.65 M(+13.2%)
Mar 2005
-
-$923.40 K(-61.9%)
-$11.18 M(-31.9%)
Dec 2004
-$16.41 M(-32.3%)
-$2.42 M(-32.4%)
-$16.41 M(-3.9%)
Sep 2004
-
-$3.58 M(-15.7%)
-$17.07 M(-2.3%)
Jun 2004
-
-$4.25 M(-30.9%)
-$17.48 M(-15.5%)
Mar 2004
-
-$6.15 M(+99.4%)
-$20.68 M(-14.7%)
Dec 2003
-$24.25 M(-46.7%)
-$3.08 M(-22.7%)
-$24.25 M(-0.9%)
Sep 2003
-
-$3.99 M(-46.5%)
-$24.46 M(-8.5%)
Jun 2003
-
-$7.45 M(-23.3%)
-$26.72 M(-23.3%)
Mar 2003
-
-$9.72 M(+195.2%)
-$34.83 M(-23.5%)
Dec 2002
-$45.53 M(-13.9%)
-$3.29 M(-47.4%)
-$45.53 M(-23.6%)
Sep 2002
-
-$6.25 M(-59.8%)
-$59.58 M(-7.6%)
Jun 2002
-
-$15.56 M(-23.8%)
-$64.48 M(+4.3%)
Mar 2002
-
-$20.42 M(+17.8%)
-$61.81 M(+16.9%)
Dec 2001
-$52.87 M(+19.5%)
-$17.34 M(+55.5%)
-$52.87 M(+18.2%)
Sep 2001
-
-$11.16 M(-13.5%)
-$44.75 M(-0.4%)
Jun 2001
-
-$12.89 M(+12.3%)
-$44.94 M(+4.0%)
Mar 2001
-
-$11.48 M(+24.6%)
-$43.21 M(-2.3%)
Dec 2000
-$44.25 M(+23.6%)
-$9.22 M(-18.8%)
-$44.25 M(-8.1%)
Sep 2000
-
-$11.35 M(+1.7%)
-$48.13 M(+8.0%)
Jun 2000
-
-$11.16 M(-10.9%)
-$44.55 M(+7.4%)
Mar 2000
-
-$12.52 M(-4.4%)
-$41.47 M(+15.9%)
Dec 1999
-$35.80 M(+186.4%)
-$13.10 M(+68.5%)
-$35.80 M(+39.3%)
Sep 1999
-
-$7.77 M(-3.8%)
-$25.70 M(+16.2%)
Jun 1999
-
-$8.08 M(+18.0%)
-$22.13 M(+45.1%)
Mar 1999
-
-$6.85 M(+128.3%)
-$15.25 M(+22.0%)
Dec 1998
-$12.50 M(+89.4%)
-$3.00 M(-28.6%)
-$12.50 M(+23.8%)
Sep 1998
-
-$4.20 M(+250.0%)
-$10.10 M(+13.5%)
Jun 1998
-
-$1.20 M(-70.7%)
-$8.90 M(+6.0%)
Mar 1998
-
-$4.10 M(+583.3%)
-$8.40 M(+27.3%)
Dec 1997
-$6.60 M(+200.0%)
-$600.00 K(-80.0%)
-$6.60 M(0.0%)
Sep 1997
-
-$3.00 M(+328.6%)
-$6.60 M(+15.8%)
Jun 1997
-
-$700.00 K(-69.6%)
-$5.70 M(+119.2%)
Mar 1997
-
-$2.30 M(+283.3%)
-$2.60 M(+18.2%)
Dec 1996
-$2.20 M
-$600.00 K(-71.4%)
-$2.20 M(+37.5%)
Sep 1996
-
-$2.10 M(-187.5%)
-$1.60 M(-420.0%)
Jun 1996
-
$2.40 M(-226.3%)
$500.00 K(-126.3%)
Mar 1996
-
-$1.90 M
-$1.90 M

FAQ

  • What is CASI Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals annual CFO year-on-year change?
  • What is the all time high quarterly CFO for CASI Pharmaceuticals?
  • What is the all time high TTM CFO for CASI Pharmaceuticals?

What is CASI Pharmaceuticals annual cash flow from operations?

The current annual CFO of CASI is -$19.97 M

What is the all time high annual CFO for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high annual cash flow from operations is -$2.20 M

What is CASI Pharmaceuticals annual CFO year-on-year change?

Over the past year, CASI annual cash flow from operations has changed by +$1.12 M (+5.32%)

What is the all time high quarterly CFO for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high quarterly cash flow from operations is $2.40 M

What is the all time high TTM CFO for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high TTM cash flow from operations is $500.00 K